IMP Scandinavia secures a 4 million DKK investment to enhance its wireless patient monitoring technology.
Target Information
IMP Scandinavia, founded by engineers from the Technical University of Denmark (DTU), is at the forefront of patient monitoring innovation. The company has developed a wireless optical sensor combined with artificial intelligence to enhance the monitoring of patients. Recently, IMP secured an investment of 4 million DKK after a successful funding round with Keystones and other experienced business angels.
During this fundraising effort, IMP's founders, Jeppe Damgaard Leth and Brian Christensen, collaborated with Christoffer Melchior, a member of the Keystones group, who played a pivotal role as a lead investor. Melchior noted the significant potential of IMP's technology to transform patient monitoring both in hospitals, nursing homes, and within the comfort of home. The non-invasive and intelligent wearable technology developed by IMP addresses a critical need within the healthcare sector, and the investor group looks forward to supporting IMP's growth journey.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
The healthcare industry in Denmark is undergoing a significant transformation, driven by the need for improved patient care and the integration of advanced technologies. With a growing emphasis on digital solutions, there is an increasing demand for
Similar Deals
DanBAN investors → LifeBoard ApS
2023
Danish Business Angels and Vækstfonden → Knowledge Gate Group
2023
Keystones
invested in
IMP Scandinavia
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $1M